CVE-2023-33363
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows...
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- None
- Integrity
- High
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.
- Record
CVE-2023-33363- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N - Weakness
- CWE-287
- Updated
- 2026-11-02
CVE List No score
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.
- Record
CVE-2023-33363- Updated
- 2026-11-02
EUVDEUVD-2023-37526 No score
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.
- Record
EUVD-2023-37526- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-8ggh-rx5r-h3jx
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows...
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.
- Record
GHSA-8ggh-rx5r-h3jx- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N - Weakness
- CWE-287
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-33363 is a high vulnerability (CVSS 7.5) in Supremainc Biostar 2, published August 3, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.56%, the 46th percentile. No source names a fixed version.